Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Drug-drug interaction between warfarin and statins: A Danish cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comment on Delanaye et al: Future perspectives regarding kidney function estimates and dose adjustments

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. Low-dose aspirin use and risk of head and neck cancer-A Danish nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Biochemical abnormalities among patients referred for celiac disease antibody blood testing in a primary health care setting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Decreased plasma lipid levels in a statin-free Danish primary health care cohort between 2001 and 2018

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Anna E Engell
  • Andreas L O Svendsen
  • Bent S Lind
  • Christen L Andersen
  • John S Andersen
  • Tora G Willadsen
  • Frederik Persson
  • Anton Pottegård
Vis graf over relationer

Initiation of statin treatment is suggested to increase the international normalised ratio (INR) among warfarin users. However, available data is limited and conflicting. We conducted a register-based cohort study to evaluate the drug-drug interaction between warfarin and statins. By linking data on INR measurements and filled prescriptions, we identified warfarin users 2000-2015 initiating simvastatin (n=1,363), atorvastatin (n=165), or rosuvastatin (n=23). Simvastatin initiation led to an increase in mean INR from 2.40 to 2.71, with INRs peaking after 4 weeks, corresponding to a mean change of 0.32 (95%CI 0.25-0.38). High-dose and low-dose simvastatin led to comparable changes (mean change 0.33 vs 0.29). Initiation of atorvastatin and rosuvastatin lead to INR increases of 0.27 (95%CI 0.12-0.42) and 0.30 (95%CI -0.09-0.69). In conclusion, initiation of simvastatin, atorvastatin, or rosuvastatin among warfarin users led to a minor increase in INR. The magnitude of this change is for most patients likely of limited clinical relevance.

OriginalsprogEngelsk
Artikelnummer14428
TidsskriftBritish Journal of Clinical Pharmacology
Vol/bind87
Udgave nummer2
Sider (fra-til)694-699
Antal sider6
ISSN0306-5251
DOI
StatusUdgivet - feb. 2021

ID: 60052930